By the Children’s Health Defense Team Among the 100 or so global players now working on experimental Covid-19 vaccines, most of the entities touted as frontrunners are obscure biotechnology and nanotechnology firms. Despite their focus on razzle-dazzle “next-generation” technologies that private foundations, the U.S. government and the military apparently find alluring, few of these companies have any prior experience successfully bringing vaccines to market. In contrast, some […]
The post Déjà Vu: GSK Recycles Its Problematic Adjuvant into Covid-19 Vaccines appeared first on BSNEWS.
Source